These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Successful Hepatitis C Eradication With Preservation of Renal Function in a Liver/kidney Transplant Recipient Using Pegylated Interferon and Ribavirin. Mukherjee S; Ariyarantha K Transplantation; 2007 Nov; 84(10):1374-5. PubMed ID: 18049127 [No Abstract] [Full Text] [Related]
26. Two consecutive episodes of acute hepatitis C with different genotypes in a hemodialysis patient responsive to PEG-interferon monotherapy. Lederer S; Zachoval R; Hasholzner U; Schiffl H Clin Nephrol; 2008 Apr; 69(4):313-6. PubMed ID: 18397710 [TBL] [Abstract][Full Text] [Related]
39. Benefit of pegylated interferon-alpha-2a/ribavirin in a patient with common variable immunodeficiency and hepatitis C virus cirrhosis after liver transplantation and splenic embolization. Foruny JR; Bárcena R; Moreno A; Blázquez J; Manzano R; Gil-Grande LA; Moreno A; Nuño J Transplantation; 2006 Jul; 82(2):289-90. PubMed ID: 16858295 [No Abstract] [Full Text] [Related]
40. Predictors of response of U.S. veterans to treatment for the hepatitis C virus. Riley TR Hepatology; 2008 Jan; 47(1):356; author reply 356-7. PubMed ID: 18161713 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]